Atea Pharmaceuticals shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.1M | 933k | 3.35 |
| 2024-06-30 | $3.1M | 935k | 3.31 |
| 2024-03-31 | $3.9M | 963k | 4.04 |
| 2023-09-30 | $3.0M | 988k | 3.00 |
| 2023-06-30 | $3.7M | 996k | 3.74 |
| 2023-03-31 | $3.7M | 1.1M | 3.35 |
| 2022-12-31 | $4.2M | 868k | 4.81 |
| 2022-09-30 | $4.7M | 826k | 5.69 |
| 2022-06-30 | $5.1M | 714k | 7.10 |
| 2022-03-31 | $6.2M | 853k | 7.22 |
| 2021-12-31 | $2.4M | 272k | 8.91 |
| 2021-09-30 | $1.1M | 30k | 35.00 |
| 2021-06-30 | $724k | 34k | 21.47 |